Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Combination treatment saves voice in patients with laryngeal cancer

03.06.2003


Patients with cancer of the larynx are likely to retain their voice and avoid surgery if they are treated simultaneously with chemotherapy and radiotherapy, say investigators who have conducted a nationwide study.



The findings are so significant they should become the new standard of care for stage III and IV laryngeal cancer, says one of the study’s lead investigators, Moshe Maor, M.D., professor of radiation oncology at The University of Texas M. D. Anderson Cancer Center.

"There is no question that this is the best treatment option for those patients who can tolerate chemotherapy," says Maor, who presented results of the eight-year, 517-patient trial during a "Best in Oncology" special session at the annual meeting of the American Society of Clinical Oncology.


The cancer, which is diagnosed in about 8,000 patients a year, usually as a result of smoking, is traditionally treated with "induction" chemotherapy followed by radiotherapy. But this study found that this standard therapy, as well as the third tested treatment of radiotherapy alone, resulted in a significantly greater rate of surgery and removal of the voice box because of cancer recurrence.

Specifically, the number of surgeries two years after treatment in patients who were treated with chemotherapy and radiotherapy together was 21, compared to 43 in patients who were treated with standard therapy, and 49 in patients who had radiotherapy alone.

"We believe that when delivered together, chemotherapy sensitizes the tumor to the killing effects of radiation," says Maor.

Because results from the two inferior treatments were the same, Maor says, the study raises the question of whether chemotherapy, when used by itself before radiotherapy, offers any benefit at all.

"Our theory is that tumors that respond to chemotherapy will respond to radiation anyway," Maor says. "Thus chemotherapy does not have an additional benefit unless used at the same time as radiotherapy."


Contact: Laura Sussman or Stephanie Dedeaux, (713) 792-0655

Laura Sussman | EurekAlert!

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

Metallic nanoparticles will help to determine the percentage of volatile compounds

20.10.2017 | Materials Sciences

Shallow soils promote savannas in South America

20.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>